Bendifallah et al reported a nomogram for predicting lymph node metastases in a woman with apparent Stage I or II endometrial cancer. These can help to identify a woman who may benefit from more aggressive management. The authors are from multiple hospitals in France.
Patient selection: woman with apparent Stage I or II endometrial cancer
Parameters:
(1) age in years, from 10 to 100 years
(2) race
(3) histologic type of cancer
(4) histologic grade
(5) depth of invasion
points for age =
Parameter |
Finding |
Points |
race |
Caucasian |
0 |
|
Black |
4.4 |
|
other |
8.1 |
histologic type |
adenocarcinoma |
0 |
|
carcinosarcoma |
7.7 |
|
clear cell |
16.1 |
|
papillary serous |
28.5 |
grade |
Grade I (well-differentiated) |
0 |
|
Grade II |
12.8 |
|
Grade III (poorly differentiated) |
26.5 |
depth of invasion |
in situ |
0 |
|
myometrial invasion, < 50% |
47.6 |
|
myometrial invasion, > 50% |
88.9 |
|
invasion of cervical stroma |
100 |
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 193
• The higher the score the greater the risk of lymph node metastases.
Score |
Percent with Lymph Node Metastases |
< 38.4 |
< 1% |
38.4 to 82.8 |
(0.09 * (points)) - 2.45 |
82.8 to 138 |
(0.005368 * ((points)^2)) - (0.7395 * (points)) + 29.47 |
138 to 184 |
(0.8499 * (points)) - 86.55 |
> 184 |
> 70% |
Purpose: To predict the chances of lymph node metastases in a woman with Stage I or II endometrial cancer using the nomogram of Bendifallah et al.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
Objective: risk factors, disease progression
ICD-10: C54.1,